NEW YORK (GenomeWeb News) — Genedata today said that Chugai Pharmaceuticals is using its Screener software to analyze high-throughput screening data.
Under the agreement, Genedata said its Tokyo-based staff has helped Chugai to integrate its AssayAnalyzer and Condoseo modules to review screening data and to evaluate compounds.
Genedata said Chugai has been using the software to help it develop drugs for cancer and for joint and bone diseases.
Financial terms of the agreement were not released.